Text size Jason Alden / Bloomberg Data on the Covid-19 vaccine in development by AstraZeneca and the University of Oxford published in The Lancet on Monday looked positive, but the stock fell after rising last week due to high expectations for the data. Shares of the US deposit receipt for …
Read More »Investors applaud when two coronavirus vaccine candidates report T-cell responses, but findings are still at an early stage
At least two experimental COVID-19 vaccines produced a T-cell response in participants in early-stage clinical trials, which may indicate a longer-lasting form of immunity than an antibody response. BioNTech BNTX, + 3.46% and Pfizer Inc. PFE, + 0.69% It said early Monday morning that an ongoing early-stage clinical trial for …
Read More »Modern falls in decline, data from the Oxford-AstraZeneca vaccine
Modern Pharmaceutical (MRNA) – Get report, one of the leading candidates to produce a viable coronavirus vaccine, fell on Monday after Oxford University and AstraZeneca (AZN) – Get report published promising data from an early-stage trial of a key coronavirus vaccine study, and the population received a downgrade from JP …
Read More »New York Governor Andrew Cuomo holds a press conference on the coronavirus outbreak
[The stream is slated to start at 9:30 a.m. ET. Please refresh the page if you do not see a player above at that time.]
Read More »AstraZeneca climbs as GlaxoSmithKline relaxes as the FTSE 100 glides
Prince William, Duke of Cambridge, wears a face mask as a precaution against the spread of COVID-19 and speaks to a patient participating in a COVID-19 vaccine trial at the Oxford Vaccine Group facility in Oxford, England, June 24, 2020. Steve Parsons / Agence France-Presse / Getty Images AstraZeneca and …
Read More »